Table of content Pharmaceutical impurities Code Product Price Unit 4-Aminobenzoic Acid O MM 0094.00 Imp. B (EP): Benzocaine (A) 500 mg O H2N MM 0093.17 Imp. C (EP) as Hydrochloride: Aniline Hydrochloride (B) 100 mg x HCl H2N Acebutolol Hydrochloride O MM 0435.00 Acebutolol Hydrochloride OH (A) 500 mg H O N O N x HCl H O MM 0435.01 Imp. A (EP): N-[3-Acetyl-4-[(2RS)-oxiran- (A) 50 mg 2-ylmethoxy]phenyl]butanamide O O O N H O MM 0435.02 Imp. B (EP) as Hydrochloride:N-[3-Acetyl-4-[(2RS)- OH (A) 100 mg 2-hydroxy-3-[(1-methylethyl)amino]- H O N O propoxy]phenyl]acetamide Hydrochloride x HCl (Diacetolol Hydrochloride) N H O MM 0435.03 Imp. C (EP): N-(3-Acetyl-4-hydroxyphenyl)butanamide (A) 100 mg OH O N H MM 0435.04 Imp. D (EP) as Hydrochloride: 1-[5-Amino-2- O (A) 50 mg OH H [(2RS)-2-hydroxy-3-[(1-methylethyl)amino]- O N x 2 HCl propoxy]phenyl]ethanone Dihydrochloride H2N OH MM 0435.05 Imp. E (EP) as Hydrochloride: N-[4-[(2RS)-2- H (A) 50 mg O N Hydroxy-3-[(1-methylethyl)amino]propoxy]- O x HCl phenyl]butanamide Hydrochloride N H O MM 0435.06 Imp. F (EP): N-[3-Acetyl-4-[(2RS)- OH (A) 50 mg 2,3-dihydroxypropoxy]phenyl]butanamide O OH O N H O O MM 0435.07 Imp. G (EP): N,N'-[[(1-Methylethyl)imino]- OH OH (A) 50 mg bis[(2-hydroxypropane-1,3-diyl)oxy(3-acetyl- O N O 1,4-phenylene)]]dibutanamide (Acebutolol Biamine) HN NH O O O O MM 0435.08 Imp. H (EP): N,N'-[(2-Hydroxypropane- OH (A) 50 mg 1,3-diyl)bis[oxy(3-acetyl-1,4-phenylene)]]di- O O butanamide HN NH O O MM 0435.09 Imp. I (EP): N-[3-Acetyl-4-[(2RS)-3-(ethylamino)- O (A) 50 mg OH H 2-hydroxypropoxy]phenyl]butanamide O N O N H O MM 0435.10 Imp. J (EP) as Hydrochloride: N-[3-Acetyl-4- OH (A) 50 mg [(2RS)-2-hydroxy-3-[(1-methylethyl)amino]- H O N O x HCl propoxy]phenyl]propanamide Hydrochloride N H O MM 0435.11 Imp. K (EP) as Hydrochloride: N-[3-Butanoyl- OH (A) 50 mg 4-[(2RS)-2-hydroxy-3-[(1-methylethyl)amino]- H O N x HCl propoxy]phenyl]butanamide Hydrochloride O N H Edition 2012/2013 All your needs for pharmaceutical analysis – email [email protected] 21 Table of content Pharmaceutical impurities Code Product Price Unit Aceclofenac MM 0181.00 Aceclofenac O (A) 250 mg O OH O NH Cl Cl MM 0006.20 Imp. A (EP): [2-[(2,6-Dichlorophenyl)amino]phenyl]acetic Acid OH (A) 100 mg (Diclofenac) O NH Cl Cl MM 0006.10 Imp. B (EP): Methyl [2-[(2,6-Dichlorophenyl)amino]phenyl]acetate O (A) 100 mg (Methyl Ester of Diclofenac) O NH Cl Cl MM 0006.11 Imp. C (EP): Ethyl 2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetate O (A) 100 mg (Ethyl Ester of Diclofenac) O NH Cl Cl MM 0181.01 Imp. D (EP): Methyl [[[2-[(2,6-Dichloro- O (A) 100 mg O phenyl)amino]phenyl]acetyl]oxy]acetate O (Methyl Ester of Aceclofenac) O NH Cl Cl MM 0181.02 Imp. E (EP): Ethyl [[[2-[(2,6-Dichlorophenyl)amino]- O (A) 100 mg O phenyl]acetyl]oxy]acetate O (Ethyl Ester of Aceclofenac) O NH Cl Cl MM 0181.03 Imp. F (EP): ): Benzyl[[[2-[(2,6-Dichlorophenyl)amino]- O (A) 100 mg O phenyl]acetyl]oxy]acetate O (Benzyl Ester of Aceclofenac) O NH Cl Cl MM 0181.04 Imp. G (EP): [[[[[2-[(2,6-Dichlorophenyl)amino]phenyl]- O (A) 100 mg O OH acetyl]oxy]acetyl]oxy]acetic Acid O (Acetic Aceclofenac) O O NH Cl Cl MM 0181.05 Imp. H (EP): [[[[[[[2-[(2,6-Dichlorophenyl)- O O (A) 50 mg amino]phenyl]acetyl]oxy]acetyl]oxy]acetyl]- O O O OH oxy]acetic Acid O O (Diacetic Aceclofenac) NH Cl Cl MM 0006.01 Imp. I (EP):1-(2,6-Dichlorophenyl)-1,3-dihydro-2H-indol-2-one (A) 100 mg O N Cl Cl O MM 0181.06 Isopropyl [2-[(2,6-Dichlorophenyl)amino]phenyl]acetate (A) 100 mg (Isopropyl Ester of Diclofenac) O NH Cl Cl Acesulfame Potassium O MM 1093.01 Imp. A (EP): 3-Oxobutanamide (Acetylacetamide) (A) 100 mg NH2 O Acetazolamide O O MM 0648.00 Acetazolamide H (A) 500 mg S S N NH2 O N N H MM 0648.04 Imp. A (EP): N-(5-Chloro-1,3,4-thiadiazol-2-yl)acetamide S (A) 50 mg Cl N N N O 22 All your needs for pharmaceutical analysis – email [email protected] Edition 2012/2013 Table of content Pharmaceutical impurities Code Product Price Unit H MM 0648.01 Imp. B (EP): N-(1,3,4-Thiadiazol-2-yl)acetamide S (A) 50 mg N N N O Acetylcysteine O MM 0024.00 N-Acetyl-L-cysteine (A) 500 mg HS OH HN O NH2 O MM 0024.03 Imp. A (EP): L-Cystine (B) 100 mg HO S S OH O NH2 O MM 0024.02 Imp. B (EP): L-Cysteine (B) 100 mg HS OH NH2 O MM 0024.04 Imp. C (EP): N,N’-Diacetyl-L-cystine (A) 100 mg NH O HO S S OH O HN O O O MM 0024.01 Imp. D (EP): N,S-Diacetyl-L-cysteine (A) 100 mg S OH HN O O MM 0024.05 Sodium 2-Methyl-4,5-dihydro-1,3-thiazol-4-carboxylate (A) 100 mg N ONa S O MM 0024.06 N-Propionyl-L-cysteine (A) 100 mg HS OH HN O Acetylsalicylic Acid O O MM 0133.00 Acetylsalicylic Acid (A) 500 mg HO O O MM 0045.01 Imp. A (EP): 4-Hydroxybenzoic Acid (B) 100 mg HO OH O O MM 0045.02 Imp. B (EP): 4-Hydroxybenzene-1,3-dicarboxylic Acid (A) 100 mg (4-Hydroxyisophthalic Acid) HO OH OH O MM 0045.00 Imp. C (EP): Salicylic Acid (A) 500 mg OH OH O MM 0133.01 Imp. D (EP): 2-[[2-(Acetyloxy)benzoyl]oxy]benzoic Acid (A) 100 mg (Acetylsalicylsalicylic Acid) OH O O O O MM 0133.03 Imp. E (EP):2-[(2-Hydroxybenzoyl)oxy]benzoic Acid O (A) 100 mg (Salicylsalicylic Acid) OH O OH O O MM 0133.02 Imp. F (EP): 2-(Acetyloxy)benzoic Anhydride (A) 100 mg (Acetylsalicylic Anhydride) O O O O O O Edition 2012/2013 All your needs for pharmaceutical analysis – email [email protected] 23 Table of content Pharmaceutical impurities Code Product Price Unit O MM 0133.04 2-(2,4-Dihydroxybenzoyl)benzoic Acid (A) 100 mg OH O OH OH O O MM 0133.08 4-Acetoxyisophthalic Acid (A) 50 mg HO OH O O O MM 0133.09 Acetylsalicylsalicylsalicylic Acid (A) 50 mg OH O O O O O O N-Acetyltryptophan H MM 1267.01 Imp. A (EP): Tryptophan N (A) 100 mg NH2 OH O H MM 0172.03 Imp. D (EP): (S)-2-Amino-3-(5-hydroxy- N (A) 100 mg NH2 1H-indol-3-yl)propanoic Acid OH (5-Hydroxy-tryptophan) O HO Aciclovir O MM 0061.00 Aciclovir (A) 500 mg N HN OH N H2 N N O O MM 0061.01 Imp. A (EP): 2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin- (A) 100 mg 9-yl)methoxy]ethyl Acetate N HN O N O H2N N O O MM 0061.02 Imp. B (EP): 2-Amino-1,7-dihydro-6H-purin-6-one (B) 100 mg H (Guanine) N HN N H2N N O New MM 0061.03 Imp. C (EP): 2-Amino-7-[(2-hydroxy- O OH (A) 100 mg ethoxy)methyl]-1,7-dihydro-6H-purin- N HN 6-one N H2N N MM 0061.04 Aciclovir Imp. D (EP): 2-[(2-Amino-6-oxo-1,6-dihydro- O (A) 100 mg 9H-purin-9-yl)methoxy]ethylBenzoate N HN O N O H2N N O O MM 0061.06 Imp. F (EP): N-[9-[(2-Hydroxyethoxy)methyl]-6-oxo- (A) 100 mg 6,9-dihydro-1H-purin-2-yl]acetamide N O HN OH N N N H O O MM 0061.07 Imp. G (EP): 2-[[(2-(Acetylamino)-6-oxo-1,6-dihydro- (A) 100 mg N O 9H-purin-9-yl]methoxy]ethyl Acetate O HN O N N N H O MM 0061.08 Aciclovir Imp. H (EP): 2-[[2-(Acetylamino)-6-oxo- O (A) 100 mg 1,6-dihydro-9H-purin-9-yl]methoxy]ethyl Benzoate N O HN O N N N O H O MM 0061.10 2,6-Dichloropurine Cl (B) 100 mg N N Cl N N H 24 All your needs for pharmaceutical analysis – email [email protected] Edition 2012/2013 Table of content Pharmaceutical impurities Code Product Price Unit Adapalene O MM 0681.03 Imp. A (EP): 2,2'-Binaphthalene-6,6'-dicarboxylic Acid (A) 50 mg HO OH O O MM 0681.01 Imp. C (EP): 1-(2-Methoxyphenyl)tricyclo- (A) 50 mg 3,7 [3.3.1.1 ]decane O New MM 0681.02 Imp. D (EP): 1,1'-[4,4'Bis(methoxy)biphenyl-3,3'- (A) 50 mg 3,7 diyl]bis(tricyclo[3.3.1.1 ]decane) O Adenosine NH 2 MM 0784.00 Adenosine (A) 500 mg N N HO N N O OH OH NH2 MM 0784.01 Imp.